U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Description
Curator's Comment: description was created based on several sources, including: https://en.wikipedia.org/wiki/Benzalkonium_chloride

Benzalkonium chloride, also known as BZK, BKC, BAC, alkyldimethylbenzylammonium chloride and ADBAC, is a type of cationic surfactant. It is an organic salt called a quaternary ammonium compound. In 2011, a large clinical trial designed to evaluate the efficacy of hand sanitizers based on different active ingredients in preventing virus transmission amongst schoolchildren was re-designed to exclude sanitizers based on benzalkonium chloride due to safety concerns. Benzalkonium chloride has been in common use as a pharmaceutical preservative and antimicrobial since the 1940s. While early studies confirmed the corrosive and irritant properties of benzalkonium chloride, investigations into the adverse effects of, and disease states linked to, benzalkonium chloride have only surfaced during the past 30 years. Benzalkonium chloride is classed as a Category III antiseptic active ingredient by the United States Food and Drug Administration. Ingredients are categorised as Category III when "available data are insufficient to classify as safe and effective, and further testing is required”. Benzalkonium chloride is excluded from the current United States Food and Drug Administration review of the safety and effectiveness of consumer antiseptics and topical antimicrobial over-the-counter drug products, meaning it will remain a Category III ingredient. The mechanism of bactericidal/microbicidal action is thought to be due to disruption of intermolecular interactions. This can cause dissociation of cellular membrane lipid bilayers, which compromises cellular permeability controls and induces leakage of cellular contents. Other biomolecular complexes within the bacterial cell can also undergo dissociation. Enzymes, which finely control a wide range of respiratory and metabolic cellular activities, are particularly susceptible to deactivation. Critical intermolecular interactions and tertiary structures in such highly specific biochemical systems can be readily disrupted by cationic surfactants. Benzalkonium chloride is a human skin and severe eye irritant. It is a suspected respiratory toxicant, immunotoxicant, gastrointestinal toxicant and neurotoxicant.

Approval Year

PubMed

PubMed

TitleDatePubMed
Upregulation of genes orchestrating keratinocyte differentiation, including the novel marker gene ID2, by contact sensitizers in human bulge-derived keratinocytes.
2010 Jan-Feb
Prediction of the contact sensitizing potential of chemicals using analysis of gene expression changes in human THP-1 monocytes.
2010 Nov 10
An in vitro test to screen skin sensitizers using a stable THP-1-derived IL-8 reporter cell line, THP-G8.
2011 Dec
Development of an in vitro alternative assay method for vaginal irritation.
2011 Jan 11
Localization and expression of zonula occludins-1 in the rabbit corneal epithelium following exposure to benzalkonium chloride.
2012
Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model.
2013 Dec
Characterizing the immunological effects of oral healthcare ingredients using an in vitro reconstructed human epithelial model.
2014 Dec
Patents

Sample Use Guides

Unknown
Route of Administration: Topical
In Vitro Use Guide
Curator's Comment: Cell exposure to 0.1% and 0.05% BAC induced cell lysis immediately after treatment. All cells (100%) treated with 0.01% BAC died in a delayed manner within 24 hours, with most of the characteristics of apoptosis (chromatin condensation and DNA fragmentation, reduction in cell volume, expression of the apoptotic marker Apo 2.7, and apoptotic changes in DNA content).
A continuous human conjunctival cell line (Wong-Kilbourne derivative of Chang conjunctiva) was exposed to benzalkonium chloride (BAC) solutions at various concentrations (0.1%-0.0001%) during a period of 10 minutes.
Substance Class Mixture
Created
by admin
on Sat Dec 16 05:35:10 GMT 2023
Edited
by admin
on Sat Dec 16 05:35:10 GMT 2023
Record UNII
151T1GQ42D
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BENZALKONIUM BROMIDE
INCI   WHO-DD  
INCI  
Official Name English
BROMOGERAMINE
Common Name English
ALKYL DIMETHYL BENZYL AMMONIUM BROMIDE
Common Name English
BENZALKONIUM BROMIDE [INCI]
Common Name English
BENZALKONIUM BROMIDE [USP-RS]
Common Name English
BROMO-GERAMINE
Common Name English
Benzalkonium bromide [WHO-DD]
Common Name English
Code System Code Type Description
RXCUI
1425981
Created by admin on Sat Dec 16 05:35:10 GMT 2023 , Edited by admin on Sat Dec 16 05:35:10 GMT 2023
PRIMARY RxNorm
FDA UNII
151T1GQ42D
Created by admin on Sat Dec 16 05:35:10 GMT 2023 , Edited by admin on Sat Dec 16 05:35:10 GMT 2023
PRIMARY
CAS
91080-29-4
Created by admin on Sat Dec 16 05:35:10 GMT 2023 , Edited by admin on Sat Dec 16 05:35:10 GMT 2023
PRIMARY
DAILYMED
151T1GQ42D
Created by admin on Sat Dec 16 05:35:10 GMT 2023 , Edited by admin on Sat Dec 16 05:35:10 GMT 2023
PRIMARY
EPA CompTox
DTXSID601041669
Created by admin on Sat Dec 16 05:35:10 GMT 2023 , Edited by admin on Sat Dec 16 05:35:10 GMT 2023
PRIMARY
DRUG BANK
DBSALT001577
Created by admin on Sat Dec 16 05:35:10 GMT 2023 , Edited by admin on Sat Dec 16 05:35:10 GMT 2023
PRIMARY
RS_ITEM_NUM
1050982
Created by admin on Sat Dec 16 05:35:10 GMT 2023 , Edited by admin on Sat Dec 16 05:35:10 GMT 2023
PRIMARY
EVMPD
SUB00713MIG
Created by admin on Sat Dec 16 05:35:10 GMT 2023 , Edited by admin on Sat Dec 16 05:35:10 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY
Definition References